Phyto Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $36.4K
Latest Deal Amount
  • Investors
  • 4

Phyto General Information

Description

Manufacturer of plant-based salt designed to reduce sodium intake. The company's salt is derived from Salicornia, a plant grown by seawater, enabling consumers to consume them to reduce high blood pressure and body fat.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Food Products
Other Industries
Agricultural Chemicals
Primary Office
  • 2nd Floor
  • Institute of Molecular Biology and Genetics, Seoul National University
  • Seoul
  • South Korea
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Phyto Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 06-Jun-2019 $36.4K Completed Startup
1. Early Stage VC 28-Apr-2014 Completed Startup
To view Phyto’s complete valuation and funding history, request access »

Phyto Executive Team (5)

Name Title Board Seat Contact Info
Deuk-Hoi Kim Founder & Chief Executive Officer
Eun Ah Cho Co-Inventor
Hyun Joo Yoon Co-Inventor
Mee Hyang Kweon Co-Inventor
Seon Yeong Park Co-Inventor
To view Phyto’s complete executive team members history, request access »

Phyto Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phyto Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Future Food Asia Corporation 000 0000 000000 0
Hanwha Investment Corporate Venture Capital Minority 000 0000 000000 0
Korea-Seoul Life Science Fund Venture Capital Minority 000 0000 000000 0
Oxford Bioscience Partners Venture Capital Minority 000 0000 000000 0
To view Phyto’s complete investors history, request access »